Newsletter | September 1, 2026

09.01.26 -- Cut The Chaos: Smarter Systems For Sites, Sponsors, And Data

SPONSOR

 

Webinar: AI Reality Check in Drug Development: What’s Real and What’s Missing

AI is advancing drug discovery and development, but realizing its full potential depends on reliable, high-quality clinical data. Join Dr. Richard Graham, co-founder of TruTechnologies, and industry experts as they explore where AI is delivering value today, where challenges remain, and how sponsors can build the foundation for more effective AI-driven decisions across the drug development lifecycle. Click here to learn more.

CLINICAL TRIAL TECHNOLOGY

 

4 Ways That AI And Point-Of-Care Diagnostics Are Redefining Clinical Trial Design And Operations

Discover how AI-enhanced point-of-care diagnostics are changing trial design and what ClinOps should do next.

 

From Frustration To Organization: An SSO Platform For Trial Sites

To reap the benefits of tech innovation, sponsors and sites need a single sign-on (SSO) solution that enables streamlined organization across different trials and clinical systems.

 

The Story Behind MIDBA: An Exclusive Interview

A new regulatory framework reduces PK bridging study needs, helping sponsors streamline device transitions, lower costs, speed up timelines, and boost regulatory predictability for combination products.

 

Achieving Data Compatibility And Navigating Hardware Evolution

Switching wearable devices mid-study doesn't have to break your data. Learn how standardized methods keep long-term trials consistent and credible.

 

Central eSource: Leveraging Site Technology

In this presentation, CRIO founder and co-CEO Raymond Nomizu delves into how sponsors can leverage the electronic source trend among sites through the use of Central eSource.

 

Unified vs. Siloed: The Hidden Cost Of Disparate eCOA And EDC

Pairing eCOA and EDC solutions will silo clinical trial systems, creating hidden inefficiencies. Learn how unifying these platforms saves an average of 1,898 hours per 24-month study.

Connect With Clinical Leader: